Related Experiment Video
Updated: May 21, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
The IL-10 promoter haplotype and cancer risk: evidence from a meta-analysis
Kui Zhang1, Lushun Zhang, Xianmin Wang
1Department of Forensic Biology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu, 610041, Sichuan, People's Republic of China.
Abstract:
Interleukin-10 (IL-10) plays a key role in immunosuppressive and anti-angiogenic process, suggesting its possible involvement in carcinogenesis. A haplotype formed by polymorphisms at positions -1082 G/A (rs1800896), -819 T/C (rs1800871), and -592 A/C (rs1800872) from the transcriptional start site in the promoter region of the IL-10 gene is a strong determinant for IL-10 production. We systematically reviewed the evidence of association between IL-10 promoter haplotype and cancer risk. Up to November 2011, databases including PubMed, and CNKI (China National Knowledge Infrastructure) were searched to access the relevant genetic association studies. Summary odds ratios and corresponding 95% confidence intervals (CIs) for this haplotype and cancer risk were estimated by using fixed or random-effect models when appropriate. Finally, 12 case-control studies with 2,090 cases and 4,224 controls were available for this study. The summary OR for cancer risk associated with the GCC haplotype was 1.47 (95 % CIs = 1.25-1.72) when compared with ATA haplotype by random effects model. Similarly, significantly increased risks were observed both in Caucasian and in Non Caucasian. Our results suggested that haplotype in IL-10 promoter was involved in the development of cancer.
Related Concept Videos
Non-LTR Retrotransposons
lncRNA - Long Non-coding RNAs
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer Prevention
Some...